Provided By PR Newswire
Last update: Oct 7, 2021
NEW YORK, Oct. 7, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
Acceleron Pharma Inc. (NASDAQ: XLRN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Merck & Co., Inc. for $180.00 per share in cash. If you are an Acceleron shareholder, click here to learn more about your rights and options.
Read more at prnewswire.com9.535
-0.3 (-3.1%)
4.06
-0.19 (-4.47%)
Find more stocks in the Stock Screener